These molecular alterations are evident in breast cancer subtypes (basal, HER2-positive, luminal A and B), HCC, GBM, and LGG, underscoring the universal relevance of the WWOX/HIF1A axis in tumour biology. Here, ERBB2 is linked to glioblastoma.